Bio-Rad Laboratories, Inc.
BIO· NYSE
Filed May 10, 2012 · 10-Q · 40 days after period end · 0000012208-12-000021
| Metric | Q1 2012 | Q1 2011 | Q1 2010 |
|---|---|---|---|
| Revenue | $486.28M | $485.10M | $454.20M |
| Net Income | $31.01M | $33.00M | $34.90M |
| EPS Diluted | $1.09 | $1.16 | $1.24 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 10, 2012 · 40 d after period end